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Delayed vitreous prolapse 
after cataract surgery: clinical 
features and surgical outcomes
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This study investigates the etiology and clinical features of delayed vitreous prolapse after cataract 
surgery and evaluates the long-term surgical and visual outcomes. Consecutive patients with vitreous 
prolapse into the anterior chamber occurring ≥ 3 months after cataract surgery at two hospitals 
between December 2006 and June 2020 were retrospectively reviewed. The primary outcome was 
associated ophthalmological events that triggered delayed vitreous prolapse. Secondary outcomes 
included long-term visual and subjective symptom changes after treatment. Among 20 eyes (20 
patients), all had visual symptoms, the most common being blurry vision (12 patients; 60%). Five 
(25%) were detected after YAG laser capsulotomy, three (15%) had a history of intraocular lens(IOL) 
implantation in sulcus due to intraoperative posterior capsular tears, three (15%) had prolapsed 
vitreous alongside dislocated IOLs, and three (15%) were aphakic after previous cataract surgeries. 
After surgical treatment, the mean corrected distance visual acuity improved from 20/50 to 
20/31(P = 0.02) and the mean preoperative intraocular pressure (IOP) that was 26.4 mmHg decreased 
to 15.6 mmHg, remaining stable until the last follow-up. All reported symptoms were relieved. YAG 
laser capsulotomy or a history of defective posterior capsule from iatrogenic causes may trigger 
delayed vitreous prolapse. The long-term outcomes were favorable, particularly after posterior 
vitrectomy, with improved IOP control and symptom resolution.
Vitreous prolapse or loss is a condition in which the vitreous gel becomes displaced beyond the posterior cap-
sule into the anterior segment of the eye. Previous reports have mentioned that the incidence of vitreous loss 
ranges from 1.4 to 3.2% during cataract surgery, and 7.65% by learning surgeons but no studies have focused 
on the prevalence of delayed vitreous loss long after the primary  surgery1–3. Additionally, few case reports have 
documented possible ophthalmological complications of vitreous prolapse, such as pupillary block glaucoma 
with intraocular pressure (IOP)  elevation4,5, or corneal decompensation leading to bullous keratopathy, cystoid 
macular edema, uveitis, or even retinal  detachment6,7.
The possible risk factors for vitreous loss during surgery are age < 40 years and  pseudoexfoliation2, while case 
reports have documented that Nd:YAG laser capsulotomy for posterior capsular opacification may induce vitre-
ous prolapse in pseudophakic  eyes4,5. However, most case series have focused on intraoperative vitreous prolapse, 
and therefore, little is known about the clinical characteristics, demographics, and outcomes of vitreous prolapse 
occurring long after the primary surgery. Only the individual case reports have been published. In addition, the 
treatment outcomes of delayed vitreous prolapse, in terms of the visual outcomes, complications, and subjec-
tive symptoms, are either poorly documented or outdated in the age of microincisional  phacoemulsification8.
In this study, we investigated the possible etiology, demographics, and clinical features of delayed vitreous 
prolapse after cataract surgery. We also evaluated the long-term surgical and visual outcomes.
Materials and methods
This was a retrospective study of patients diagnosed with vitreous prolapse between December 2006 and June 
2020 at two high-volume, referral-based tertiary hospitals: Severance Eye Hospital and Gangnam Severance 
Hospital, affiliated with Yonsei University College of Medicine. Institutional Review Board (IRB) approval was 
obtained from Gangnam Severance Hospital IRB (No 3-2020-0371), and the study adhered to the tenets of the 
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Declaration of Helsinki. The requirement for informed consent was waived by the Gangnam Severance Hospital 
IRB due to the retrospective nature of the study with no identifying feature or figure that requires additional 
patient consent.
Study selection. We included patients with vitreous prolapse into the anterior chamber occurring at least 
3 months after the initial surgery. After a careful review of the electronic medical records of all included cases, 
we excluded all patients with an underlying ophthalmological anatomical or trauma event that occurred within 
the 3 months before the diagnosis of vitreous prolapse. Thus, we excluded patients who suffered vitreous loss 
after an intraoperative posterior capsule rupture, during any other surgical procedure, or immediately after an 
ocular traumatic event.
Data collection. All patient demographics, clinical, and ocular features were evaluated using electronic 
records or imaging data. The patients’ slit photo images were also assessed. Visual acuity (VA) was measured 
using a Snellen chart and converted to the logarithm of the minimum angle of resolution (logMAR) for statisti-
cal purposes. IOP was mainly measured using a Goldmann applanation tonometer and/or a rebound tonometer 
(iCare; Revenio, Vantaa, Finland). Endothelial cell counts (cells/mm2) were measured using specular micros-
copy (Konan Noncon Robo SP8000 or Konan NonCon Cellchek XL NSP-9000; Konan Medical Inc., Hyogo, 
Japan), while axial lengths (mm) were measured using either the IOL-master 600 or IOL-master 700 (Zeiss 
Meditec AG, Jena, Germany). Central macular thickness (CMT) and the presence of intraretinal fluid (IRF) or 
subretinal fluid (SRF) were analyzed using optical coherence tomography (OCT; Heidelberg Engineering, Hei-
delberg, Germany). Patient symptoms were retrieved from the electronic documents and checked for subjective 
improvement at each follow-up visit.
Surgical technique. Surgery was performed by experienced retinal specialists (M.K. and H.J.K). When 
complete vitrectomy was deemed necessary by the attending surgeon, a standard three-port vitrectomy was 
performed using a 25-gauge system (Constellation; Alcon Laboratories, Fort Worth, TX, USA). Anterior vitrec-
tomy was performed using the Centurion Vision System (Alcon, Fort Worth, Texas, USA). All surgeons used 
triamcinolone acetonide (Maqaid, Wakamoto Pharmaceuticla Co., Ltd., Tokyo, Japan) for the visualization of 
vitreous in anterior and posterior segment and to completely remove vitreous during the vitrectomy procedure.
Main outcome measures. The primary outcome was associated ophthalmological events that triggered 
delayed vitreous prolapse. Secondary outcomes included long-term corrected distance visual acuity (CDVA), 
intraocular pressure, and subjective visual symptom changes after treatment.
Statistical analysis. We analyzed the data using SPSS software version 25.0 (IBM Corp., Armonk, NY, 
USA). Variables such as VA and IOP were compared between groups set according to post-operative time peri-
ods using two-sample paired t-tests after testing for normality using the Kolmogorov–Smirnov test. A P-value 
of < 0.05 was considered to be statistically significant.
Results
Among 199 cases with vitreous prolapse, 179 with prolapse occurring intraoperatively or immediately following 
cataract surgery were excluded, and twenty eyes from 20 (10%) patients with delayed prolapse who met the inclu-
sion criteria were included. The baseline characteristics are summarized in Table 1. The mean age was 60 years 
(median: 59 years, range: 43–82 years), with a male preponderance (16 males; 80%). The mean follow-up duration 
was 48 months (median: 30 months, range: 1–143 months) after the diagnosis of vitreous prolapse. The mean 
duration from cataract surgery to vitreous prolapse was 94 months, ranging from 3 to 498 months (> 40 years).
All 20 patients had visual symptoms, the most common being blurry vision (12 patients; 60%), followed by 
decreased VA (four patients; 20%). The mean initial VA at the first visit was logMAR 0.41 (Snellen equivalent: 
20/50, range: 20/500 to 20/20), which had improved to logMAR 0.19 (Snellen equivalent: 20/31, range: 20/125 to 
20/20) at the patients’ most recent visit. The mean IOP before treatment for vitreous prolapse was 26.35 mmHg 
(median: 26 mmHg, range: 14–42 mmHg), with 11 cases (55%) of elevated IOP (> 22 mmHg), and a mean 
endothelial count of 2042 cells/mm2 (median: 2227 cells/mm2, range: 529–2976 cells/mm2). All 11 patients had 
acute IOP elevation along with visual symptoms when the slit lamp examination first revealed vitreous loss. The 
mean axial length was 24.14 mm (median: 24.2 mm, range: 22.82–25.08 mm). Surgical treatment was performed 
a mean of 119 days after the diagnosis of vitreous loss (median: 9 days, range: 3–1318 days), and no new severe 
complications occurred during this period.
Previous surgical history prior to detection of vitreous loss. The patients’ previous ophthalmologi-
cal history before the diagnosis of delayed vitreous prolapse are summarized in Table 2. Five patients (25%) had 
symptoms manifest after YAG laser capsulotomy, three (15%) had a previous surgical history of intraocular lens 
(IOL) implantation in the ciliary sulcus due to intraoperative posterior capsular tears, three (15%) had prolapsed 
vitreous alongside IOL dislocation, and three (15%) were aphakic after previous cataract surgeries performed 
in the 1980s. Those patients presenting with dislocated IOLs did not have a history of ocular trauma, or records 
indicating complications during cataract surgery, such as capsular ruptures or in-sulcus IOL placement. The 
cause of vitreous prolapse was unknown in six pseudophakic patients (30%) with seemingly intact posterior 
capsules and no identifiable zonular weakness or pseudophacodonesis. Gangnam Severance Hospital and Sever-
ance Eye Hospital had 70 cases (2.5%) of posterior capsular tear among 2775 cataract surgeries in 2019. During 
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Table 1.  Baseline characteristics for patients with delayed vitreous prolapse. Age, visual acuity, and intraocular 
pressure displayed as mean ± SD. N displayed as number (%). Follow-up duration = post-operative follow-up 
period after surgical intervention for the prolapse. FC = 2.00 logMAR, HM = 2.30 logMAR, LP = 2.60 logMAR, 
no light perception = 2.90 logMAR. logMAR logarithm of the minimal angle of resolution.
Baseline characteristics (n = 20, 20 eyes)




Hypertension, n (%) 7 (35.0%)
Diabetes, n (%) 0 (0.0%)
Visual Symptoms 20 (100.0%)
 Blurring 12 (60.0%)




Duration from cataract surgery to prolapse (months) 94.3 ± 136.2 (median: 38.6, 3.4–498.1)
Visual acuity, logMAR (Snellen equivalent)
At first visit 0.41 ± 0.46 (20/50)
At last visit 0.19 ± 0.25 (20/31)
Intraocular pressure (mmHg)
Pre-operation 26.35 ± 9.12 (14–42)
Post-operation 15.57 ± 2.80 (11–21)
Pre-operative endothelial cell count (cells/mm2) 2042.58 (529–2976)
Axial length (mm) 24.14 ± 0.51 (22.82–25.08)
Follow up duration (months) 48.37 (1–143)
Table 2.  Patient factors and treatment of vitreous prolapse. Age, visual acuity, intraocular pressure 
displayed as mean ± SD N displayed as number (%). logMAR logarithm of the minimal angle of resolution, 
IOL intraocular lens, Nd:YAG neodymium-doped yttrium aluminum garnet.
Patient factors and treatment (n = 20, 20 eyes)
Previous ophthalmologic history
Nd: YAG laser, n (%) 5 (25.0%)
IOL in sulcus + posterior capsular tear during surgery, n (%) 3 (15.0%)
IOL dislocation, n (%) 3 (15.0%)
Aphakia, n (%) 3 (15.0%)
None (unknown cause) 6 (30.0%)
Duration from prolapse to surgical treatment (days) 118.6 (median: 17, 3–1318)
Ocular comorbidity
Glaucoma 7(35.0%)
 Primary open angle glaucoma 5 (25.0%)
 Secondary glaucoma (d/t uveitis) 2 (10.0%)
Central retinal vein occlusion 1 (5.0%)
None 12 (60.0%)
Treatment for vitreous removal
Anterior vitrectomy, n (%) 13 (65.0%)
Trans pars plana vitrectomy, n (%) 7 (35.0%)
Relapse rate 0%
Post-operative remnant vitreous 1 (5.0%)
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our study period, three cases (1.5%) among 199 cases of vitreous prolapse met our study’s inclusion criteria of 
delayed prolapse and were caused by posterior capsular tear which is a rare incidence.
In terms of past ophthalmic history, seven patients had a history of glaucoma, among whom five (25%) were 
diagnosed with primary open angle glaucoma and two (10%) with secondary glaucoma due to uveitis; one 
patient had a history of central retinal vein occlusion. Finally, the rest (12 patients; 60%) had no other history 
of ocular comorbidities. Slit lamp examination revealed no pseudoexfoliation in seven patients with the history 
of glaucoma.
Treatment for vitreous prolapse. Surgical treatment was performed in all 20 patients: 13 (65%) received 
anterior vitrectomy and seven (35%) underwent posterior pars plana vitrectomy. One patient underwent ante-
rior vitrectomy for remnant vitreous in the chamber identified immediately after surgery, while all other cases 
showed no relapse of vitreous loss. Three patients had vitreous loss alongside dislocated (IOL): two received 
simple IOL repositioning and one had his IOL exchanged.
Long-term visual outcomes and complications. Overall, vision improved significantly after vitreous 
removal, with the mean post-operative corrected distance VA (CDVA) improving to logMAR 0.26 ± 0.29 (Snel-
len equivalent: 20/37, range: 20/200 to 20/20; P = 0.042) at 1 month. This improvement was maintained until 
the patients’ last visit, at which the mean logMAR was 0.20 (Snellen equivalent: 20/31, range: 20/125 to 20/20; 
P = 0.02).
The mean IOP had decreased to 15.7 ± 3.9 mmHg (P < 0.001) 1 month after surgery, and 15.0 ± 2.3 (P = 0.002) 
after 6 months. The IOP remained stable at 15.6 ± 2.8 mmHg (P < 0.001) until the patients’ last visit. After surgery, 
seven of the 11 patients (63.6%) with elevated IOP had at least one of their anti-glaucoma eye drops discontinued. 
The same patients also ceased oral intake of IOP-lowering systemic carbonic anhydrase inhibitors. We tracked 
the visual symptoms of all 20 patients summarized in Table 1. The five symptoms which were blurring, vision 
decrease, floaters, injection, and flashes, had disappeared 1 month after surgery. The visual and IOP outcomes 
are listed in Table 3, along with representative images from before and after the removal of prolapsed vitreous 
in Fig. 1.
We additionally checked the CMT and the presence of IRF or SRF using OCT of patients with vitreous pro-
lapse and no patients showed any signs of macular edema or retinal fluid. The mean central macular thickness 
was 267.2 ± 39.0 μm (median 273.4 μm, range: 198 to 319). We re-analyzed the OCT of patient with CMT of 
more than 300 μm and no overt IRF, SRF, or cystic change was found, which could be deemed as a subclinical 
thickening of central macula.
In one patient, we assessed endothelial cell count before and after vitreous prolapse. The cell count decreased 
from 2280 cells/mm2 8 months before the prolapse to 1470 cells/mm2 8 months after the detection. This patient 
received anterior vitrectomy to remove the prolapse. We identified one patient with severe complications leading 
to low vision and bullous keratopathy requiring penetrating keratoplasty. However, this particular patient already 
had a pre-surgical specular count of 800 cells/mm2 and had been warned of the risk of corneal decompensation 
after surgery.
Table 3.  Outcomes in patients after removal of vitreous prolapse. Average post-operative follow-up duration: 
48 months. Values displayed as mean ± SD. Visual outcomes compared to initial visual acuity. Two-sample 
paired t tests. A P-value less than 0.05 considered statistically significant. Normality test done using the 
Kolmogorov–Smirnov test. All groups followed normal distribution (P > 0.05). FC = 2.00 logMAR, HM = 2.30 
logMAR, LP = 2.60 logMAR, no light perception = 2.90. IOP intraocular pressure.
Outcomes in patients after removal of vitreous prolapse (n = 20)
Vision P-value IOP P-value Symptoms (n = 20)
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Discussion
In this study, we retrospectively reviewed patients with delayed vitreous prolapse occurring after intraocular 
surgery or a traumatic ocular event, documenting the clinical and demographic characteristics and long-term 
outcomes in these patients. In particular, over a quarter of our patients experienced symptomatic vitreous loss 
after YAG laser capsulotomy, and over 15% had a prior history of intraoperative posterior capsular tear neces-
sitating IOL implantation in the ciliary sulcus. Both of these factors may have led to the delayed prolapse of 
vitreous gel into the anterior chamber. Vitreous prolapse caused various visual discomfort (reduced VA, floaters, 
flashes), and over 50% of patients suffered from IOP elevation requiring numerous anti-glaucoma medications. 
Surgical treatment resulted in significant and sustained improvement of vision, symptoms, and IOP, which 
was evident from the first month after surgery and lasted until the most recent visit after a mean follow-up of 
48 months. One patient with already poor endothelial count experienced unfavorable outcomes, while the rest 
experienced no complications.
Vitreous prolapse is a surgical complication of cataract surgery that can induce macular edema, corneal 
decompensation, glaucoma, and retinal detachment. The incidence rates vary among different studies from 1.7 
to 7.7% depending on the surgeon’s  experience9. Occasional case reports have mentioned that delayed vitreous 
prolapse is likely caused by Nd:YAG laser capsulotomy. The authors of one such report postulated that lasers 
disrupt the anterior vitreous face, causing vitreous prolapse into anterior  segment10. When performing Nd:YAG 
laser capsulotomy, surgeons should not extend the margin beyond the edge of the optic to avoid vitreous hernia-
tion and loss around the  optic11. Minimizing energy by targeting the appropriate central optical zone is crucial 
to prevent vitreous prolapse.
Some studies have mentioned the risk factors that contribute to an increased likelihood of vitreous loss 
during phacoemulsification. They include deep-set eyes, narrow palpebral fissures, high myopia, and previous 
history of vitreous  loss12. Our patients with delayed vitreous prolapse had an axial length of 24.09 ± 0.55 mm, 
which is not in the range of high myopic axial length generally defined as longer than 26.0 mm and spherical 
equivalent of -6D or  worse13. This indicates that the risk factors for delayed vitreous loss differ from those for 
intraoperative vitreous prolapse.
The subjective symptoms experienced by these patients are poorly reported. In our own series, we found that 
patients presented with visual symptoms, ranging from blurred vision (57.1%) and VA decrease (23.8%) to flashes 
of light. Thus, even simple symptoms that may indicate posterior vitreous detachment or floaters should not be 
overlooked. Ophthalmologists should perform diligent anterior segment evaluations using slit lamp microscopy 
to detect delayed vitreous loss, especially in patients with a history of intraoperative posterior capsule rupture 
or recent YAG laser capsulotomy.
Overall visual prognosis was favorable after the vitreous prolapse was treated. All 20 patients underwent sur-
gical removal of the prolapsed vitreous via either anterior vitrectomy (62.0%) or pars plana vitrectomy (38.0%); 
none of the patients showed recurrent vitreous prolapse. Although not every patient achieved perfect CDVA 
recovery of 20/20 or more due to their ocular comorbidity and history of glaucoma, uveitis, ECC reduction 
or CRVO after the surgical treatment, the CDVA always improved along with symptoms resolution and IOP 
reduction. The patients’ elevated IOP also significantly decreased to normal IOP ranges after vitreous removal. 
In terms of anterior versus pars plana vitrectomy, Ryoo et al. showed that 23-gauge pars plana vitrectomy had 
less post-operative complications than anterior vitrectomy when removing prolapsed vitreous during cataract 
 surgery14. Our current study also implied that pars plana vitrectomy is beneficial for vitreous removal in the 
Figure 1.  Pre-operative and post-operative external photograph of an eye with vitreous prolapse. The patient 
was a 55-year-old male who presented with a chief complaint of flashes and increased intraocular pressure of 
37.9 mmHg in his right eye. (A) Vitreous prolapse at initial presentation. Pigment cells were observed in the 
anterior chamber vitreous, but dilated fundus examination revealed no sign of retinal break or detachment. 
(B) Successfully removed vitreous prolapse after trans pars plana vitrectomy. After the surgical treatment, IOP 
decreased from 37.9 to 11 mmHg with improved visual discomfort. The notch in the patient’s nasal iris was 
present before the surgical removal of vitreous.
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long-term, as one patient had remnant vitreous in anterior chamber after anterior vitrectomy. For the case of 
remnant vitreous after initially receiving anterior vitrectomy, the surgeon confirmed the complete removal of 
vitreous by triamcinolone staining and pupil constriction as is the standard protocol at our centers; however, the 
recurrence of vitreous prolapse in the immediate postoperative period may indicate that there was (1) vitreous 
concealed in the posterior chamber, or (2) loose vitreous that remained trapped in the vitreous cavity due to grav-
ity during surgery, but subsequently may have protruded again by ocular movement right afterwards. Altogether, 
this case highlights the need for careful and thorough evaluation of the posterior chamber and peripheral iris, 
and may indicate that performing pars plana vitrectomy for more complete removal of the vitreous gel would 
be advantageous in these complication cases. Since pars plana vitrectomy allows more complete and thorough 
vitrectomy, and it may be more reliable. Moreover, performing the pars plana vitrectomy allows additional benefit 
of managing the well-recognized complication of vitreous prolapse like retinal tear.
With regard to the quality of life after the procedure, surgical treatment of vitreous prolapse alleviated all 
visual discomfort, without any aggravation, until the patients’ last visit. Considering that vitreous loss can induce 
considerable ocular complications, surgeons should consider surgical removal of prolapsed vitreous once a 
diagnosis is made, even if the condition does not immediately harm the patient.
This study was limited because it was retrospective, and therefore, we could not control all the baseline char-
acteristics. Furthermore, partly due to the study design, we could not closely analyze the change in endothelial 
cell count, which may have been affected by vitreous touching the corneal endothelium. Patients with delayed 
prolapse were usually referred to our institution by other clinics, and therefore data regarding their preopera-
tive endothelial cell density counts were unavailable for analysis. In addition, we were unable to find a definite 
cause of prolapse in six patients (30.0%). However, the strength of the study was that we presented a series of 
patients with a rare surgical complication. This allowed us to suggest possible etiologies for the delay in vitreous 
loss, present possible risk factors, and document both the clinical spectrum and long-term treatment outcomes. 
Further clinical studies focusing on the causal relationship between different factors and delayed vitreous prolapse 
are necessary to better understand this rare complication.
In conclusion, delayed vitreous prolapse after cataract surgery can be caused by YAG laser capsulotomy or 
previous surgical history of posterior capsular tear. The long-term anatomical and visual outcomes of removing 
vitreous prolapse are favorable, especially in the case of pars plana vitrectomy, with improved visual acuity, IOP 
control and reduced symptoms. Ophthalmologists should be aware of the possibility of vitreous prolapse when 
performing YAG laser capsulotomy and should actively treat once the prolapse is noted.
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